Oncolines launches assay for long COVID and cancer immunotherapy target IDO2 Oncolines launches assay for long COVID and cancer immunotherapy target IDO2 Oncolines launches assay for long COVID and cancer immunotherapy target IDO2 The tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase 2 (IDO2) is [...] yvonne2024-10-22T16:37:46+02:00News, News on Homepage| Read More